Baseline clinical variables and treatment modalities
| Variables | N (%) | Median (IQR) |
|---|---|---|
| Age | 63 (40–88) | |
| Pretreatment NIHSS | 10 (0–29) | |
| Time to procedure (days) | 5 (3–364) | |
| No of men | 16 (66) | |
| Hypertension | 19 (76) | |
| Diabetes mellitus | 8 (32) | |
| Coronary artery disease | 4 (16) | |
| Atrial fibrillation | 2 (8) | |
| Smoking | 8 (32) | |
| Hyperlipidemia | 14 (56) | |
| ICA terminus | 2 (8) | |
| M1 | 4 (16) | |
| BA | 9 (36) | |
| VA | 9 (36) | |
| Bare metal balloon mounted stent | 16 (64) | |
| Drug eluting stent | 7 (28) | |
| PTA only | 1 | |
| TICI > 2b | 25 (100) | |
| TICI 3 | 23 (92) | |
| Immediate post-treatment residual stenosis >20% | 2/16 (8) |
BA, basilar artery; ICA, internal carotid artery; M1, first branch of the middle cerebral artery; NIHSS, National Institutes of Health Stroke Scale; PTA, percutaneous balloon angioplasty; TICI, Thrombolysis in Cerebral Infarction; VA, vertebral artery.